Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer

NCT00363766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

DRUG: LY573636-sodium

Sponsor

Eli Lilly and Company